Stockreport

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115 [Yahoo! Finance]

Vivani Medical, Inc.  (VANI) 
PDF The NPM-115 clinical program will consist of a series of studies designed to support the development of Vivani's miniature, 6-month GLP-1 (exenatide) NanoPortal ™ impla [Read more]